Skip Nav Destination
Issues
1 February 2008
-
Cover Image
Cover Image
Near infrared imaging of excised tumors and organs 6 hours after injection of 0.5 nmol LLP2A-Cy5.5, a fluorochrome-conjugated α4β1 integrin-targeting peptidomimetic. LLP2A-Cy5.5 conjugate was accumulated primarily in the Molt-4 tumors. LLP2A retention in other normal organs was low, with little uptake in lymph node and skin except for the kidney. For details, see Peng et al. in this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1535-7163
EISSN 1538-8514
Issue Sections
Review
Research Articles: Therapeutics, Targets, and Development
Caspase-, cathepsin-, and PERK-dependent regulation of MDA-7/IL-24-induced cell killing in primary human glioma cells
Adly Yacoub; Margaret A. Park; Pankaj Gupta; Mohammed Rahmani; Guo Zhang; Hossein Hamed; David Hanna; Devanand Sarkar; Irina V. Lebedeva; Luni Emdad; Moira Sauane; Nicollaq Vozhilla; Sarah Spiegel; Costas Koumenis; Martin Graf; David T. Curiel; Steven Grant; Paul B. Fisher; Paul Dent
Regulation of GST-MDA-7 toxicity in human glioblastoma cells by ERBB1, ERK1/2, PI3K, and JNK1-3 pathway signaling
Adly Yacoub; Pankaj Gupta; Margaret A. Park; Mohammed Rhamani; Hossein Hamed; David Hanna; Guo Zhang; Devanand Sarkar; Irina V. Lebedeva; Luni Emdad; Costas Koumenis; David T. Curiel; Steven Grant; Paul B. Fisher; Paul Dent
6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol, a specific glutathione S-transferase inhibitor, overcomes the multidrug resistance (MDR)-associated protein 1–mediated MDR in small cell lung cancer
Giuseppe Filomeni; Paola Turella; Maria Luisa Dupuis; Olindo Forini; Maria Rosa Ciriolo; Maurizio Cianfriglia; Silvia Pezzola; Giorgio Federici; Anna Maria Caccuri
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds